1. Home
  2. FOXA vs INSM Comparison

FOXA vs INSM Comparison

Compare FOXA & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Corporation

FOXA

Fox Corporation

HOLD

Current Price

$67.99

Market Cap

27.2B

Sector

Industrials

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$107.73

Market Cap

22.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXA
INSM
Founded
2018
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.2B
22.4B
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
FOXA
INSM
Price
$67.99
$107.73
Analyst Decision
Buy
Strong Buy
Analyst Count
19
24
Target Price
$79.85
★ $194.18
AVG Volume (30 Days)
★ 5.2M
3.8M
Earning Date
11-02-2026
10-29-2026
Dividend Yield
★ 0.83%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.20
N/A
Revenue
★ $14,913,000,000.00
N/A
Revenue This Year
$4.80
$206.35
Revenue Next Year
N/A
$60.57
P/E Ratio
$31.66
★ N/A
Revenue Growth
★ 6.72
N/A
52 Week Low
$48.34
$90.39
52 Week High
$76.39
$212.75

Technical Indicators

Market Signals
Indicator
FOXA
INSM
Relative Strength Index (RSI) 63.65 56.78
Support Level $61.73 $105.07
Resistance Level N/A $119.54
Average True Range (ATR) 2.47 4.25
MACD 0.32 2.36
Stochastic Oscillator 95.21 73.17

Price Performance

Historical Comparison
FOXA
INSM

About FOXA Fox Corporation

Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay-TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay-TV bundle. The Murdoch family controls Fox.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: